HPV18 E7 Antibodies

Santa Cruz Biotechnology features a diverse variety of HPV18 E7 monoclonal antibodies for research focused on understanding HPV18 E7 protein's role in cellular processes. HPV18 E7 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HPV18 E7 protein functions as a key oncoprotein that drives the transformation of host cells, promoting cell cycle progression and inhibiting apoptosis. The interaction between HPV18 E7 and host cell proteins, particularly retinoblastoma (Rb), highlights its significance in the development of cervical cancer and other HPV-related malignancies. Research focusing on HPV18 E7 continues to reveal new insights about viral oncogenesis and potential therapeutic targets. Understanding HPV18 E7's molecular mechanisms and cellular interactions is crucial for developing targeted therapies and improving diagnostic methods for HPV-associated diseases. Investigating HPV18 E7's role in cancer development requires reliable detection methods and precise experimental tools. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of HPV-related cancers and developing new therapeutic strategies.